Javelin Pharmaceuticals (JAV) Reports Third Quarter 2009 Results
11/10/2009 9:39:18 AM
More...
|
Javelin Pharmaceuticals (JAV) to Announce Third Quarter 2009 Financial Results
11/4/2009 9:00:45 AM
More...
|
Javelin Pharmaceuticals (JAV) Tops Up Balance Sheet Through Registered Direct Offering
10/30/2009 9:37:45 AM
More...
|
Javelin Pharmaceuticals (JAV) Reports Second Quarter 2009 Results and Corporate Highlights
8/11/2009 10:14:06 AM
More...
|
Javelin Pharmaceuticals (JAV) Pain Drug Ereska (Intranasal Ketamine) Misses Key Phase 3 Study Goal
8/11/2009 7:59:30 AM
More...
|
Javelin Pharmaceuticals (JAV) to Host Second Quarter 2009 Conference Call
8/4/2009 9:07:19 AM
More...
|
Javelin Pharmaceuticals (JAV) Completes Open Label Safety Study of Dyloject(TM)
6/23/2009 9:45:16 AM
More...
|
New Study Shows Javelin Pharmaceuticals (JAV)'s Dyloject(TM) Well-Tolerated in High-Risk Patients with Impaired Renal and Hepatic Function
6/15/2009 9:51:57 AM
More...
|
Javelin Pharmaceuticals (JAV) Reports First Quarter 2009 Results and Corporate Highlights
5/7/2009 9:33:10 AM
More...
|
Javelin Pharmaceuticals (JAV) to Announce First Quarter 2009 Financial Results
5/5/2009 9:42:56 AM
More...
|
|